SARS-CoV-2 Vaccines in Kidney Transplant Recipients: Will They Be Safe and Effective and How Will We Know?
作者信息
Heldman Madeleine R, Limaye Ajit P
机构信息
Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington.
出版信息
J Am Soc Nephrol. 2021 May 3;32(5):1021-1024. doi: 10.1681/ASN.2021010023. Epub 2021 Mar 24.
Abstract
摘要
相似文献
1
SARS-CoV-2 Vaccines in Kidney Transplant Recipients: Will They Be Safe and Effective and How Will We Know?肾移植受者的新冠病毒2型疫苗：它们会安全有效吗？我们又如何得知？
J Am Soc Nephrol. 2021 May 3;32(5):1021-1024. doi: 10.1681/ASN.2021010023. Epub 2021 Mar 24.
2
Cellular and Humoral Immune Responses After 3 Doses of BNT162b2 mRNA SARS-CoV-2 Vaccine in Kidney Transplant.肾移植受者接种 3 剂 BNT162b2 mRNA SARS-CoV-2 疫苗后的细胞和体液免疫反应
Transplantation. 2021 Nov 1;105(11):e267-e269. doi: 10.1097/TP.0000000000003903.
3
Improved immunogenicity against SARS-CoV-2 in a solid-organ transplant recipient by switching vaccines.通过更换疫苗提高实体器官移植受者对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的免疫原性。
Clin Microbiol Infect. 2021 Oct;27(10):1529-1530. doi: 10.1016/j.cmi.2021.06.022. Epub 2021 Jun 27.
4
Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients.血液透析患者和肾移植受者队列中 SARS-CoV-2 mRNA 疫苗接种后的体液反应。
J Am Soc Nephrol. 2021 Sep;32(9):2153-2158. doi: 10.1681/ASN.2021040490. Epub 2021 Jun 16.
5
COVID-19 vaccination in our transplant recipients: The time is now.新冠病毒疫苗在我们移植受者中的应用：现在是时候了。
J Heart Lung Transplant. 2021 Mar;40(3):169-171. doi: 10.1016/j.healun.2020.12.009. Epub 2021 Jan 2.
6
Safety and Immunogenicity of Anti-SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants.实体器官移植受者中抗SARS-CoV-2信使核糖核酸疫苗的安全性和免疫原性
Ann Intern Med. 2021 Sep;174(9):1336-1338. doi: 10.7326/M21-1341. Epub 2021 May 25.
7
Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients.成年移植受者中出现SARS-CoV-2突破性感染的风险。
Transplantation. 2021 Nov 1;105(11):e265-e266. doi: 10.1097/TP.0000000000003907.
8
Humoral immunity to SARS-CoV-2 in kidney transplant recipients and dialysis patients: IgA and IgG patterns unraveled after SARS-CoV-2 infection and vaccination.肾移植受者和透析患者对 SARS-CoV-2 的体液免疫：SARS-CoV-2 感染和接种疫苗后解析的 IgA 和 IgG 模式。
Virol J. 2024 Jun 13;21(1):138. doi: 10.1186/s12985-024-02410-1.
9
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.实体器官移植受者接种第三剂新冠病毒疫苗的安全性和免疫原性：病例系列
Ann Intern Med. 2021 Sep;174(9):1330-1332. doi: 10.7326/L21-0282. Epub 2021 Jun 15.
10
Antibody Response to SARS-CoV-2 mRNA Vaccine Among Kidney Transplant Recipients.肾移植受者对SARS-CoV-2 mRNA疫苗的抗体反应
Exp Clin Transplant. 2022 Nov;20(11):1048. doi: 10.6002/ect.2022.0176.
引用本文的文献
1
Changes regarding solid organ transplantation during the COVID-19 pandemic.新冠疫情期间实体器官移植的相关变化。
World J Transplant. 2025 Sep 18;15(3):100591. doi: 10.5500/wjt.v15.i3.100591.
2
Low switched memory B cells are associated with no humoral response after SARS-CoV-2 vaccine boosters in kidney transplant recipients.低转换记忆 B 细胞与肾移植受者接种 SARS-CoV-2 疫苗加强针后无体液免疫反应相关。
Front Immunol. 2023 Oct 24;14:1202630. doi: 10.3389/fimmu.2023.1202630. eCollection 2023.
3
Booster Dose of SARS-CoV-2 mRNA Vaccine in Kidney Transplanted Patients Induces Wuhan-Hu-1 Specific Neutralizing Antibodies and T Cell Activation but Lower Response against Omicron Variant.肾移植患者接种 SARS-CoV-2 mRNA 疫苗加强针可诱导产生针对武汉株的中和抗体和 T 细胞激活，但对奥密克戎变异株的反应较低。
Viruses. 2023 May 9;15(5):1132. doi: 10.3390/v15051132.
4
Organ Procurement from Potential Donors with a History of COVID-19 Vaccination.从有新冠病毒疫苗接种史的潜在供体获取器官。
Tanaffos. 2022 Feb;21(2):109-110.
5
Prevalence of COVID-19 in Kidney Transplant Patients in Relation to Their Immune Status after Repeated Anti-SARS-CoV-2 Vaccination.肾移植患者重复接种抗SARS-CoV-2疫苗后COVID-19的流行情况与其免疫状态的关系
Pathogens. 2023 Feb 19;12(2):351. doi: 10.3390/pathogens12020351.
6
Availability and prioritisation of COVID-19 vaccines among patients with advanced chronic kidney disease and kidney failure during the height of the pandemic: a global survey by the International Society of Nephrology.在大流行高峰期，患有晚期慢性肾脏病和肾衰竭的患者中 COVID-19 疫苗的供应和优先排序：国际肾脏病学会的全球调查。
BMJ Open. 2022 Dec 30;12(12):e065112. doi: 10.1136/bmjopen-2022-065112.
7
Torquetenovirus viral load is associated with anti-spike antibody response in SARS-CoV-2 mRNA BNT162b2 vaccinated kidney transplant patients.Torquetenovirus 病毒载量与接受 SARS-CoV-2 mRNA BNT162b2 疫苗接种的肾移植患者的抗刺突抗体反应相关。
Clin Transplant. 2022 Dec;36(12):e14825. doi: 10.1111/ctr.14825. Epub 2022 Nov 23.
8
Immunogenicity and safety of two-dose SARS-CoV-2 vaccination different platforms in kidney transplantation recipients.两种不同平台的 SARS-CoV-2 疫苗接种在肾移植受者中的免疫原性和安全性。
Front Immunol. 2022 Sep 16;13:951576. doi: 10.3389/fimmu.2022.951576. eCollection 2022.
9
Kidney transplantation during mass disasters - from COVID-19 to other catastrophes A Consensus Statement by the DESCARTES Working Group and Ethics Committee of the ERA.重大灾害期间的肾脏移植 - 从 COVID-19 到其他灾难 DES-CARTES 工作组和 ERA 伦理委员会的共识声明。
Nephrol Dial Transplant. 2023 Feb 13;38(2):300–308. doi: 10.1093/ndt/gfac251. Epub 2022 Sep 6.
10
Safety and Tolerability of mRNA COVID-19 Vaccines in Kidney Transplant Recipients.mRNA COVID-19 疫苗在肾移植受者中的安全性和耐受性。
Transplant Proc. 2022 May;54(4):878-883. doi: 10.1016/j.transproceed.2022.02.025. Epub 2022 Mar 17.
本文引用的文献
1
COVID-19 vaccination in our transplant recipients: The time is now.新冠病毒疫苗在我们移植受者中的应用：现在是时候了。
J Heart Lung Transplant. 2021 Mar;40(3):169-171. doi: 10.1016/j.healun.2020.12.009. Epub 2021 Jan 2.
2
Maintaining Safety with SARS-CoV-2 Vaccines.通过新冠病毒疫苗维持安全性。
N Engl J Med. 2021 Feb 18;384(7):643-649. doi: 10.1056/NEJMra2035343. Epub 2020 Dec 30.
3
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.ChAdOx1 nCoV-19 疫苗（阿斯利康）对 SARS-CoV-2 的安全性和有效性：巴西、南非和英国四项随机对照试验的中期分析。
Lancet. 2021 Jan 9;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8.
4
Alternative strategies of posttransplant influenza vaccination in adult solid organ transplant recipients.成人实体器官移植受者移植后流感疫苗接种的替代策略。
Am J Transplant. 2021 Mar;21(3):938-949. doi: 10.1111/ajt.16295. Epub 2020 Sep 23.
5
Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）与人体组织之间潜在的抗原交叉反应性，可能与自身免疫性疾病增加有关。
Clin Immunol. 2020 Aug;217:108480. doi: 10.1016/j.clim.2020.108480. Epub 2020 May 24.
6
Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice.实体器官移植候选人和受者的疫苗接种：美国移植感染病学会实践社区指南。
Clin Transplant. 2019 Sep;33(9):e13563. doi: 10.1111/ctr.13563. Epub 2019 Jun 5.
7
Overview of Vaccine Adjuvants: Introduction, History, and Current Status.疫苗佐剂概述：引言、历史与现状
Methods Mol Biol. 2017;1494:1-13. doi: 10.1007/978-1-4939-6445-1_1.
8
Adenovirus infections in immunocompetent and immunocompromised patients.免疫功能正常和免疫功能低下患者的腺病毒感染
Clin Microbiol Rev. 2014 Jul;27(3):441-62. doi: 10.1128/CMR.00116-13.
9
Adenoviral vector immunity: its implications and circumvention strategies.腺病毒载体免疫：其意义和规避策略。
Curr Gene Ther. 2011 Aug;11(4):307-20. doi: 10.2174/156652311796150372.
Zotero 插件